| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the Diagnosis and Treatment of Advanced Non–Small-Cell Lung Cancer With EGFR Exon 20 Insertion Mutation
|
Liu, Jingwen
|
|
|
25 |
2 |
p. 100-108
|
artikel
|
| 2 |
ALK Rearrangement Positive Lung Adenocarcinoma in Pregnancy Treated With Alectinib: A Case Report
|
Gonzalez-Mosquera, Luis F.
|
|
|
25 |
2 |
p. e77-e80
|
artikel
|
| 3 |
A Multicenter Study Assessing the Real-World Use and Effectiveness of First-Line Chemotherapy Plus Immunotherapy in Advanced Small-Cell Lung Cancer (SCLC) Patients
|
Porte, Marie
|
|
|
25 |
2 |
p. e101-e111.e2
|
artikel
|
| 4 |
A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
|
Qin, Angel
|
|
|
25 |
2 |
p. 128-134
|
artikel
|
| 5 |
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research
|
Prelaj, Arsela
|
|
|
25 |
2 |
p. 190-195
|
artikel
|
| 6 |
Barriers to Timely Lung Cancer Care in Early Stage Non–Small Cell Lung Cancer and Impact on Patient Outcomes
|
Pirzadeh, Mina
|
|
|
25 |
2 |
p. 135-143
|
artikel
|
| 7 |
Brief Report: Updated Efficacy and Safety Data From an Integrated Analysis of Entrectinib in Locally Advanced/Metastatic ROS1 Fusion-Positive Non–Small-Cell Lung Cancer
|
Fan, Yun
|
|
|
25 |
2 |
p. e81-e86.e4
|
artikel
|
| 8 |
Clinical and Genomic Characterization of Long-Term Responders Receiving Immune Checkpoint Blockade for Metastatic Non–Small-Cell Lung Cancer
|
Ghanem, Paola
|
|
|
25 |
2 |
p. 109-118
|
artikel
|
| 9 |
Comments on “Effect of Surgical Treatment for N2-Positive c-Stage III Non–Small Cell Lung Carcinoma in the “PACIFIC” Era”
|
Ohri, Nitin
|
|
|
25 |
2 |
p. e75-e76
|
artikel
|
| 10 |
Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors (SABR-DETECT)
|
Verma, Saurav
|
|
|
25 |
2 |
p. e87-e91
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
25 |
2 |
p. A1
|
artikel
|
| 12 |
HIV Associated Lung Cancer: Unique Clinicopathologic Features and Immune Biomarkers Impacting Lung Cancer Screening and Management
|
Cali Daylan, Ayse Ece
|
|
|
25 |
2 |
p. 159-167
|
artikel
|
| 13 |
In-depth Analysis of Lorlatinib-related neurocognitive Adverse Events in Patients With Non–small-cell Lung Cancer
|
Schoenmaekers, Janna
|
|
|
25 |
2 |
p. 168-174.e1
|
artikel
|
| 14 |
Lack of Association Between Immunotherapy and Improvement of Survival for Non-small Cell Lung Cancer Patients With Hemodialysis: A Nationwide Retrospective Cohort Study
|
Sawa, Kenji
|
|
|
25 |
2 |
p. 144-150.e3
|
artikel
|
| 15 |
Niraparib for the Treatment of Metastatic NSCLC in a Patient With BRCA2 Germinal Mutation: A Case Report
|
Inno, Alessandro
|
|
|
25 |
2 |
p. 175-179
|
artikel
|
| 16 |
Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non–Small-Cell Lung Cancer
|
Hui, Caressa
|
|
|
25 |
2 |
p. e92-e100.e4
|
artikel
|
| 17 |
Pembrolizumab Plus Chemotherapy Per PD-L1 Stratum In Patients With Metastatic Non–Small Cell Lung Cancer: Real-World Effectiveness Versus Trial Efficacy
|
Verschueren, Marjon V.
|
|
|
25 |
2 |
p. 119-127.e1
|
artikel
|
| 18 |
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II Trial
|
Hui, Caressa
|
|
|
25 |
2 |
p. 186-189
|
artikel
|
| 19 |
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort
|
Borghetti, Paolo
|
|
|
25 |
2 |
p. 151-158
|
artikel
|
| 20 |
Sufficient Multidisciplinary Discussion Can Make Patients’ Outcomes Better in the Treatment for Stage III Non–Small-Cell Lung Carcinoma - Reply to Ohri et al.
|
Adachi, Hiroyuki
|
|
|
25 |
2 |
p. e73-e74
|
artikel
|
| 21 |
Table of Contents
|
|
|
|
25 |
2 |
p. A3-A6
|
artikel
|
| 22 |
Trial Design and Optimal Determination of CNS Activity of Small Molecule Targeted Therapy in NSCLC
|
Jennings, Elaine M.
|
|
|
25 |
2 |
p. 91-99
|
artikel
|
| 23 |
Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report
|
Ardeshir-Larijani, Fatemeh
|
|
|
25 |
2 |
p. 180-185.e1
|
artikel
|
Tijdschrift beschrijving